Being born is the most challenging event mankind will experience. 10% of newborns do not breath. Because of oxygen shortage 7% of this group will face disability for the rest of the life and 7% will die. NeoStartTrack will safe lives and costs for society.
Professional support in the first 5 minutes of life is crucial to avoid oxygen shortage. Technically it is complicated to provide adequate ventilation. No adequate feedback on actions is available with conventional equipment.
Guidelines prescribe, in addition to a conventional stethoscope, to use oxygen saturation bands and ECG patches to obtain objective and numeric information about ventilation and heart rate. It takes on average 90 seconds to get a reliable signal from ECG measurement at newborns. Oxygen saturation is not a valuable parameter in the first 10 minutes. These devices do not give feedback on ventilation efforts, while this is key to improve oxygenation.
NeoStartTrack is an innovative medical device that will give instant feedback on ventilation effectiveness and heart rate range. This enables direct and adequate adaptation of treatment. Due to smart sensor technology supported with state-of-the-art algorithms, NeoStartTrack provides an instant and reliable signal on ventilation and heart frequency.
With a capital investment of €1.3 million, NeoStartTrack can be developed, validated and implemented; This device can help to prevent brain damage and death by providing better care in the first 5 minutes of life.
T I M E I S B R A I N
The product will be developed by: 1. Marc Jonkers, a pediatrician with >25 years of experience in multiple hospitals and countries; 2. Luuk Evers, business developer at Pontes Medical University Medical Hospital Utrecht (UMCU) with > 30 years of experience with product development and > 12 years of experience with business development of medical devices; 3 Oda Heerema, product manager at Pontes Medical UMCU with > 10 years of experience with product development; 4. Bert Westra, electronic expert and Jesse Bosma, designer of medical devices; both working in the UMCU ISO 13485 certified production lab.
- Venture Challenge Fall 2018
Oda Heerema | O.Snoep@umcutrecht.nl